Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Singular Genomics Systems Inc (NQ: OMIC )

21.80 -0.09 (-0.43%)
Streaming Delayed Price Updated: 1:50 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,811
Open 21.61
Bid (Size) 20.67 (1)
Ask (Size) 21.90 (1)
Prev. Close 21.90
Today's Range 21.61 - 21.90
52wk Range 5.340 - 23.41
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Singular Genomics Reports Recent Updates and Third Quarter 2024 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga

Performance

YTD
+49.86%
+49.86%
1 Month
+60.57%
+60.57%
3 Month
+207.55%
+207.55%
6 Month
+99.68%
+99.68%
1 Year
+90.77%
+90.77%

More News

Read More
Why Yum China Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Singular Genomics Sys: Q4 Earnings Insights
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital
From Singular Genomics Systems, Inc.
Via GlobeNewswire
$1.8M Bet On Singular Genomics? Check Out These 3 Stocks Executives Are Buying
Via Benzinga
Dow Jumps 400 Points; Adobe Shares Plummet After Q3 Results
Via Benzinga
Topics Stocks
Exposures US Equities
What's Going On With Singular Genomics Stock Friday?
Via Benzinga
Singular Genomics Receives Non-Binding Acquisition Proposal from Deerfield
From Singular Genomics Systems, Inc.
Via GlobeNewswire
OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Singular Genomics Reports Recent Highlights and Second Quarter 2024 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Report Second Quarter 2024 Financial Results on August 13, 2024
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Singular Genomics Systems, Inc.
Via GlobeNewswire
OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Misses Revenue for Q2 2023
Via InvestorPlace
Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday
Via Benzinga
Singular Genomics Announces 1-for-30 Reverse Stock Split
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference
From Singular Genomics Systems, Inc.
Via GlobeNewswire
OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Singular Genomics Reports Recent Highlights and First Quarter 2024 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Report First Quarter 2024 Financial Results on May 14, 2024
From Singular Genomics Systems, Inc.
Via GlobeNewswire
OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Beats Revenue for Q4 2023
Via InvestorPlace
Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Earnings Scheduled For March 18, 2024
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.